- Abstract viewed - 2199 times
- PDF downloaded - 1629 times
- Untitled downloaded - 0 times
- Untitled downloaded - 0 times
Copyright
© Clujul Medical, 2019
Affiliations
Ovidiu Vasile Bochis
Institute of Oncology "Prof.Dr. Ion Chiricuta", Cluj-Napoca, Romania
University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
Bogdan Fetica
Institute of Oncology "Prof.Dr. Ion Chiricuta", Cluj-Napoca, Romania
University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
Catalin Vlad
Institute of Oncology "Prof.Dr. Ion Chiricuta", Cluj-Napoca, Romania
University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
Patriciu Achimas-Cadariu
Institute of Oncology "Prof.Dr. Ion Chiricuta", Cluj-Napoca, Romania
University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
Alexandru Irimie
Institute of Oncology "Prof.Dr. Ion Chiricuta", Cluj-Napoca, Romania
University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
How to Cite
The importance of ubiquitin E3 ligases, SCF and APC/C, in human cancers
Abstract
A normal evolution of the cell-cycle phases consists of multiple consecutive events, which makes it a highly complex process. Its preservation is regulated by Cyclin-Cdks (cyclin-dependent kinases) interactions and protein degradation, which is often controlled by the ubiquitin-mediated proteolysis.
The goal of this review is to emphasize the most important features of the regulation of the cell-cycle involved in cancerogenesis, by presenting the involvement of E3 ubiquitin ligases SCF (Skp1-Cul1-F-box protein) and APC/C (Anaphase-promoting complex/cyclosome) in human malignancies. Also, we discuss the importance of the ubiquitin proteasome pathway blockade in cancer treatment. We know that a better understanding of the regulatory biology of the cell cycle can lead to the development of new target therapies for cancer.